Shareholders that lost money on DexCom, Inc. (DXCM) Urged to Join Class Action - Contact The Gross Law Firm to Learn More

Core Points - The Gross Law Firm has issued a notice to shareholders of DexCom, Inc. regarding a class action lawsuit for alleged misleading statements and undisclosed information related to the company's glucose monitoring products [1][2]. Allegations - The complaint alleges that DexCom made unauthorized design changes to its G6 and G7 glucose monitoring devices, which rendered them less reliable and posed health risks to users [1]. - It is claimed that the enhancements to the G7 device were overstated, and the company downplayed the severity of the issues related to the G7 devices [1]. - The allegations suggest that these actions increased the risk of regulatory scrutiny and potential legal, reputational, and financial harm to DexCom [1]. Class Action Details - The class period for the lawsuit is from January 8, 2024, to September 17, 2025, and shareholders are encouraged to register for participation by December 26, 2025 [2]. - Shareholders who register will receive updates on the case through a portfolio monitoring software [2]. Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and illegal business practices [3].